Woodline Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.7M | Buy |
305,454
+648
| +0.2% | +$112K | 0.28% | 87 |
|
|
2025
Q1 | $47.5M | Sell |
304,806
-12,836
| -4% | -$2M | 0.31% | 94 |
|
|
2024
Q4 | $43.7M | Buy |
317,642
+82,624
| +35% | +$11.4M | 0.3% | 97 |
|
|
2024
Q3 | $35.1M | Buy |
235,018
+36,252
| +18% | +$5.41M | 0.3% | 109 |
|
|
2024
Q2 | $27.1M | Buy |
198,766
+2,736
| +1% | +$373K | 0.26% | 120 |
|
|
2024
Q1 | $29.6M | Buy |
196,030
+179,881
| +1,114% | +$27.2M | 0.27% | 114 |
|
|
2023
Q4 | $2.03M | Buy |
+16,149
| New | +$2.03M | 0.02% | 374 |
|
|
2023
Q2 | – | Sell |
-304,796
| Closed | -$32.7M | – | 632 |
|
|
2023
Q1 | $32.7M | Buy |
304,796
+209,683
| +220% | +$22.5M | 0.44% | 63 |
|
|
2022
Q4 | $11.6M | Sell |
95,113
-116,280
| -55% | -$14.2M | 0.16% | 184 |
|
|
2022
Q3 | $21.8M | Buy |
211,393
+105,267
| +99% | +$10.9M | 0.31% | 92 |
|
|
2022
Q2 | $9.87M | Sell |
106,126
-5,886
| -5% | -$547K | 0.15% | 178 |
|
|
2022
Q1 | $13.1M | Sell |
112,012
-112,437
| -50% | -$13.2M | 0.21% | 142 |
|
|
2021
Q4 | $30.2M | Buy |
+224,449
| New | +$30.2M | 0.43% | 49 |
|
|
2020
Q1 | – | Sell |
-55,284
| Closed | -$7.69M | – | 139 |
|
|
2019
Q4 | $7.69M | Buy |
+55,284
| New | +$7.69M | 0.31% | 78 |
|